ESMO Congress 2024: Outcomes of patients (pts) with unfavourable, non-squamous cancer of unknown primary (CUP) progressing after induction chemotherapy (CTX) in the global, open-label, phase II CUPISCO study Poster:200P - Outcomes of patients (pts) with unfavourable, non-squamous cancer of unknown primary (CUP) progressing after induction chemotherapy (CTX) in the global, open-label, phase II CUPISCO studyThis research is being presented at ESMO Congress 2024. View all presentation abstracts at esmo.org.For more information about Foundation Medicine at ESMO Congress 2024, visit the event page here. September 10, 2024